Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Home
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
$
30.00
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 2 Articles
Tags:
eduard-parellada
,
ethnicityrace
,
health-disparities
,
illness-characteristics
,
ipolar-disorder
,
md
,
msc
,
phd
Description
Description
Eduard Parellada, MD, MSc, PhD
DRUG DISPOSITION & PHARMACOKINETICS
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
Eduard Parellada, MD, MSc, PhD
Related products
Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
$
30.00
Add to cart
Details
Divalproex in the Treatment of Bipolar Disorder
$
30.00
Add to cart
Details
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
$
30.00
Add to cart
Details
Page load link
Go to Top